Pro-apoptotic signaling in neuronal cells following iron and amyloid beta peptide neurotoxicity

Journal of Neurochemistry

Volumn 86, Issue 1, 2003, Pages 114-125

  Kuperstein, Faina ^a   Yavin, Ephraim ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Alzheimer's disease; Iron; Neuronal cell death; Oxidative stress; PKC; Signal transduction

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AMYLOID BETA PROTEIN; CASPASE 3; CASPASE 9; DEFEROXAMINE; IRON; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN BAD; PROTEIN BCL 2; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN SERINE THREONINE KINASE; WORTMANNIN;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; NERVE CELL; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; CARRIER PROTEINS; CASPASES; CELLS, CULTURED; DEFEROXAMINE; DRUG SYNERGISM; ENZYME INHIBITORS; IRON; IRON CHELATING AGENTS; ISOENZYMES; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0038647463     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01831.x     Document Type: Article

References (82)

1. Alcantara O., Obeid L., Hannun Y., Ponka P. and Boldt D. H. (1994) Regulation of protein kinase C (PKC) expression by iron: effect of different iron compounds on PKC-beta and PKC-alpha gene expression and role of the 5′-flanking region of the PKC-beta gene in the response to ferric transferrin. Blood 84, 3510-3517.
2. Arbuzova A., Schmitz A. A. and Vergeres G. (2002) Cross-talk unfolded: MARCKS proteins. Biochem. J. 362, 1-12.
3. Atwood C. S., Huang X., Moir R. D., Tanzi R. E. and Bush A. I. (1999) Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease. Met. Ions Biol. Syst. 36, 309-364.
4. Atwood C. S., Scarpa R. C., Huang X., Moir R. D., Jones W. D., Fairlie D. P., Tanzi R. E. and Bush A. I. (2000) Characterization of copper interactions with Alzheimer amyloid beta peptides, identification of an attomolar-affinity copper binding site on amyloid beta1-42. J. Neurochem. 75, 1219-1233.
5. Barrow C. J., Yasuda A., Kenny P. T. and Zagorski M. G. (1992) Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease: analysis of circular dichroism spectra. J. Mol Biol. 225, 1075-1093.
6. Behl C. (1997) Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease. Cell Tissue Res. 290, 471-480.
7. Behl C. (2000) Apoptosis and Alzheimer's disease. J. Neural Transm. 107, 1325-1344.
8. Boldt D. H. (1999) New perspectives on iron: an introduction. Am. J. Med. Sci. 318, 207-212.
9. Braak H. and Braak E. (1997) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 18, 351-357.
10. Bradford M. M. (1986) A rapid sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 238-259.
11. Brand A., Gil S. and Yavin E. (2000) N-Methyl bases of ethanolamine prevent apoptotic cell death induced by oxidative stress in cells of oligodendroglia origin. J. Neurochem. 74, 1596-1604.
12. Brunet A., Datta S. R. and Greenberg M. E. (2001) Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr. Opin. Neurobiol. 11, 297-305.
13. Butterfield D. A., Drake J., Pocernich C. and Castegna A. (2001) Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol Med. 7, 548-554.
14. Chauhan A., Chauhan V., Brockerhoff H. and Wisniewski H. (1991) Action of amyloid beta-protein on protein kinase C activity. Life Sci. 49, 1555-1562.
15. Cherny R. A., Atwood C. S., Xilinas M. E., Gray D. N., Jones W. D., McLean C. A., Barnham K. J., Volitakis I., Fraser F. W., Kim Y., Huang X., Goldstein L. E., Moir R. D., Lim J. T., Beyreuther K., Zheng H., Tanzi R. E., Masters C. L. and Bush A. I. (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30, 665-676.
16. Chong Y. H., Sung J. H., Shin S. A., Chung J. H. and Suh Y. H. (2001) Effects of the beta-amyloid and C-terminal fragment of Alzheimer's amyloid precursor protein on the production of TNF-{alpha) and matrix metalloproteinase-9 by human monocytic THP-1. J. Biol. Chem. 276, 23511-23517.
17. Clark E. A., Leach K. L., Trojanowski J. Q. and Lee V. M. Y. (1991) Characterization and differentional distribution of the three major human PKC isozymes (PKC-alpha, PKC-beta and PKC-gamma) of the central nervous system in normal and AD brains. Lab. Invest. 6, 35-44.
18. Cole G., Dobkins K. R., Hansen L. A., Terry R. D. and Saitoh T. (1988) Decreased levels of protein kinase C in Alzheimer brain. Brain Res. 452, 165-174.
19. Combs, C. K., Johnson D. E., Cannady S. B., Lehman T. M. and Landreth G. E. (1999) Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins. J. Neurosci. 19, 928-939.
20. Cotman C. W. (1997) The beta-amyloid peptide, peptide self-assembly, and the emergence of biological activities. A new principle in peptide function and the induction of neuropathology. Ann. NY Acad. Sci. 814, 1-16.
21. Cuajungco M. P., Faget K. Y., Huang X., Tanzi R. E. and Bush A. I. (2000) Metal chelation as a potential therapy for Alzheimer's disease. Ann. N Y Acad. Sci. 920, 292-304.
22. Daniels W. M., Hendricks J., Salie R. and Taljaard J. J. (2001) The role of the MAP-kinase superfamily in beta-amyloid toxicity. Metab. Brain Dis. 16, 175-185.
23. Dudek H., Datta S. R., Franke T. F., Birnbaum M. J., Yao R., Cooper G. M., Segal R. A., Kaplan D. R. and Greenberg M. E. (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science. 275, 661-665.
24. Glenner G. G. and Wong C. W. (1984) Alzheimer's disease, initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
25. Gnjec A., Fonte J. A., Atwood C. and Martins R. N. (2002) Transition metal chelator therapy - a potential treatment for Alzheimer's disease? Front Biosci. 7, 1016-1023.
26. Goodman Y. and Mattson M. P. (1994) Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. Exp. Neurol. 128, 1-12.
27. Grant S. M., Morinville A., Maysinger D., Szyf M. and Cuello A. C. (1999) Phosphorylation of mitogen-activated protein kinase is altered in neuroectodermal cells overexpressing the human amyloid precursor protein 751 isoform. Brain Res. Mol Brain Res. 72, 115-120.
28. Han H., Wang H., Long H., Nattel S. and Wang Z. (2001) Oxidative preconditioning and apgptosis in 1-cells. Roles of protein kinase B and mitogen-activated protein kinases. J. Biol. Chem, 276, 26357-26364.
29. Harkany T., Dijkstra I. M., Oosterink B. J., Horvath K. M., Abraham I., Keijser J., Van der Zee E. A. and Luiten P. G. (2000) Increased amyloid precursor protein expression and serotonergic sprouting following excitotoxic lesion of the rat magnocellular nucleus basalis: neuroprotection by Ca(2+) antagonist nimodipine. Neuroscience 101, 101-114.
30. Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., Floyd R. A. and Butterfield D. A. (1994) A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide, relevance to Alzheimer disease. Proc. Natl Acad. Sci. USA 91, 3270-3274.
31. Hensley K., Floyd R. A., Zheng N. Y., Nael R., Robinson K. A., Nguyen X., Pye Q. N., Stewart C. A., Geddes J., Markesbery W. R., Patel E., Johnson G. V. and Bing G. (1999) p38 kinase is activated in the Alzheimer's disease brain. J. Neurochem. 72, 2053-2058.
32. Huang X., Atwood C. S., Hartshorn M. A., Multhaup G., Goldstein L. E., Scarpa R. C., Cuajungco M. P., Gray D. N., Lim J., Moir R. D., Tanzi R. E. and Bush A. I. (1999) The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry. 38, 7609-7616.
33. Kanski J., Varadarajan S., Aksenova M. and Butterfield D. A. (2002) Role of glycine-33 and methionine-35 in Alzheimer's amyloid beta-peptide 1-42-associated oxidative stress and neurotoxicity. Biochim. Biophys. Acta. 1586, 190-198.
34. Katzman R. and Saitoh T. (1991) Advances in Alzheimer's disease. FASEB J. 4, 278-286.
35. Kihara T., Shimohama S., Sawada H., Honda K., Nakamizo T., Shibasaki H., Kume T. and Akaike A. (2001) Alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. J. Biol. Chem. 276, 13541-13546.
36. Koistinaho M, Kettunen M. I., Goldsteins G., Keinanen R., Salminen A., Ort M., Bures J., Liu D., Kauppinen R. A., Higgins L. S. and Koistinaho J. (2002) Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation. Proc. Natl Acad. Sci. USA 99, 1610-1615.
37. Kontush A. (2001) Amyloid-beta: an antioxidant that becomes a prooxidant and critically contributes to Alzheimer's disease. Free Radic. Biol. Med. 31, 1120-1131.
38. Koo E. H., Park L. and Selkoe D. J. (1993) Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth. Proc. Natl Acad. Sci. USA 90, 4748-4752.
39. 1-40-dependent ERK activation and enhances cell toxicity in primary neuronal cultures. Neurosci. Lett. 55, S31.
40. Kuperstein F. and Yavin E. (2002) ERK activation and nuclear translocation in amyloid-β peptide and iron-stressed neuronal cell cultures. Eur. J. Neurosci. 16, 44-54.
41. Kuperstein F., Reiss N., Koudinova N. V. and Yavin E. (2001) Biphasic modulation of protein kinase C and enhanced cell death by amyloid beta peptide and anoxia in neuronal cultures. J. Neurochem. 76, 758-767.
42. Lorenzo A. and Yankner B. A. (1994) Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl Acad. Sci. USA 91, 12243-12247.
43. Luo Y., Hawver D. B., Iwasaki K., Sunderland T., Roth G. S. and Wolozin B. (1997) Physiological levels of beta-amyloid peptide stimulate protein kinase C in PC12 cells. Brain Res. 769, 287-295.
44. Lynch T., Cherny R. A. and Bush A. I. (2000) Oxidative processes in Alzheimer's disease, the role of abeta-metal interactions. Exp. Gerontol. 35, 445-451.
45. Martin D., Salinas M., Lopez-Valdaliso R., Serrano E., Recuero M. and Cuadrado A. (2001) Effect of the Alzheimer amyloid fragment Abeta (25-35) on Akt/PKB kinase and survival of PC12 cells. J. Neurochem. 78, 1000-1008.
46. Masliah E., Cole G., Shimohama S., Hansen L., DeTereza R., Terry R. D. and Saitoh T. (1990) Differential involvement of PKC isozymes in AD. J. Neurosci. 10, 2113-2124.
47. 2+-independent protein kinase C changes in the brain of patients with Alzheimer's disease. J. Neurochem. 67, 317-323.
48. Mattson M. P. (1996) Calcium and free radicals: mediators of neurotrophic factor and excitatory transmitter-regulated developmental plasticity and cell death. Perspect. Dev. Neurobiol. 3, 79-91.
49. Mattson M. P. (1997) Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77, 1081-1132.
50. Mattson M. P., Cheng B., Culwell A. R., Esch F. S., Lieberburg I. and Rydel R. E. (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron 10, 243-254.
51. McDonald D. R., Bamberger M. E., Combs C. K. and Landreth G. E. (1998) Beta-amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J. Neurosci. 18, 4451-4460.
52. Mills J. and Reiner P. B. (1999) Regulation of amyloid precursor protein cleavage. J. Neurochem. 72, 443-460.
53. Mudher A., Chapman S., Richardson J., Asuni A., Gibb G., Pollard C., Killick R., Iqbal T., Raymond L., Varndell I., Sheppard P., Makoff A., Gower E., Soden P. E., Lewis P., Murphy M., Golde T. E., Rupniak H. T., Anderton B. H. and Lovestone S. (2001) Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase. J. Neurosci. 21, 4987-4995.
54. Nakai M., Tanimukai S., Yagi K., Saito N., Taniguchi T., Terashima A., Kawamata T., Yamamoto H., Fukunaga K., Miyamoto E. and Tanaka C. (2001) Amyloid beta protein activates PKC-delta and induces translocation of myristoylated alanine-rich C kinase substrate (MARCKS) in microglia. Neurochem. Int. 38, 593-600.
55. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E. K., Jones P. K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C. S., Petersen R. B. and Smith M. A. (2001) Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60, 759-767.
56. Olariu A., Tran M. H., Yamada K., Mizuno M., Hefco V. and Nabeshima T (2001) Memory deficits and increased emotionality induced by beta-amyloid (25-35) are correlated with the reduced acetylcholine release and altered phorbol dibutyrate binding in the hippocampus. J. Neural Transm. 108, 1065-1079.
57. Pyo H., Jou I., Jung S., Hong S. and Joe E. H. (1999) Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia. Neuroreport 9, 871-874.
58. Rapoport M. and Ferreira A. (2000) PD98059 prevents neurite degeneration induced by fibrillar beta-amyloid in mature hippocampal neurons. J. Neurochem. 274, 125-133.
59. Rossner S., Mendla K., Schliebs R. and Bigl V. (2001) Protein kinase Calpha and beta1 isoforms are regulators of alpha-secretory proteolytic processing of amyloid precursor protein in vivo. Eur J. Neurosci. 13, 1644-1648.
60. Rottkamp C. A., Raina A. K., Zhu X., Gaier E., Bush A. I., Atwood C. S., Chevion M., Perry G. and Smith M. A. (2001) Redox-active iron mediates amyloid-beta toxicity. Free Radic. Biol. Med. 30, 447-450.
61. Salinas M., Martin D., Alvarez A. and Cuadrado A. (2001) Akt1/ PKBalpha protects PC12 cells against the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium and reduces the levels of oxygen-free radicals. Mol. Cell Neurosci. 17, 67-77.
62. Santiard-Baron D., Gosset P., Nicole A., Sinet P. M., Christen Y. and Ceballos-Picot I. (1999) Identification of beta-amyloid-responsive genes by RNA differential display, early induction of a DNA damage-inducible gene, GADD45. Exp. Neurol. 158, 206-213.
63. Savage M. J., Lin Y G., Ciallella J. R., Flood D. G. and Scott R. W. (2002) Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition. J. Neurosci. 22, 3376-3385.
64. Selkoe D. (1994) Alzheimer's disease, a central role for amyloid. J. Neuropathol. Exp. Neurol. 53, 438-447.
65. Selkoe D. (1996) Amyloid β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271, 18295-18298.
66. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J. and Swindlehurst C. (1992) Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 359, 325-327.
67. Simakajornboon N., Szerlip N. J., Gozal E., Anonetapipat J. W. and Gozal D. (2001) In vivo PDGF beta receptor activation in the dorsocaudal brainstem of the rat prevents hypoxia-induced apoptosis via activation of Akt and BAD. Brain Res. 895, 111-118.
68. Smith M. A., Rottkamp C. A., Nunomura A., Raina A. K. and Perry G. (2000) Oxidative stress in Alzheimer's disease. Biochim. Biophys. Acta 1502, 139-144.
69. Smith M. A., Drew K. L., Nunomura A., Takeda A., Hirai K., Zhu X., Atwood C. S., Raina A. K., Rottkamp C. A., Sayre L. M., Friedland R. P. and Perry G. (2002) Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs? Neurochem. Int. 40, 527-531.
70. Smits H. A., de Vos N. M., Wat J. W., van der Bruggen T., Verhoef J. and Nottet H. S. (2001) Intracellular pathways involved in TNF-alpha and superoxide anion release by Aβ(1-42)-stimulated primary human macrophages. J. Neuroimmunol. 115, 144-151.
71. Stein T. D. and Johnson J. A. (2002) Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J. Neurosci. 22, 7380-7388.
72. ++ binding sites. Biochem. Mol. Biol. Int. 40, 285-293.
73. Uryu K., Laurer H., McIntosh T., Pratico D., Martinez D., Leight S., Lee V. M. and Trojanowski J. Q. (2002) Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis. J. Neurosci. 22, 446-454.
74. Varadarajan S., Yatin S., Aksenova M. and Butterfield D. A. (2000) Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J. Struct. Biol. 130, 184-208.
75. Wang X., McCullough K. D., Franke T. F. and Holbrook N. J. (2000) Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J. Biol. Chem. 275, 14624-14631.
76. Whitson J. S., Glabe C. G., Shintani E., Abcar A. and Cotman C. W. (1990) Beta-amyloid protein promotes neuritic branching in hippocampal cultures. Neurosci. Lett. 110, 319-324.
77. Wyss-Coray T., McConlogue L., Kindy M., Schmidt A. M., Du Yan S. and Stern D. M. (2001) Key signaling pathways regulate the biological activities and accumulation of amyloid-beta. Neurobiol. Aging 22, 967-973.
78. Yuan J. and Yankner B. A. (2000) Apoptosis in the nervous system. Nature 407, 802-809.
79. Zhou H., Li X. M., Meinkoth J. and Pittman R. N. (2000) Akt regulates cell survival and apoptosis at a postmitochondrial level. J. Cell Biol. 151, 483-494.
80. Zhang L., Rubinow D. R., Xaing G., Li B. S., Chang Y. H., Maric D., Barker J. L. and Ma W. (2001a) Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt. Neuroreport 12, 1919-1923.
81. Zhang L., Xing G. Q., Barker J. L., Chang Y., Maric D., Ma W., Li B. S. and Rubinow D. R. (2001b) Alpha-lipoic acid protects rat cortical neurons against cell death induced by amyloid and hydrogen peroxide through the Akt signalling pathway. Neurosci. Lett. 312, 125-128.
82. Zhu G., Wang D., Lin Y. H., McMahon T., Koo E. H. and Messing R. O. (2001) Protein kinase C epsilon suppresses Abeta production and promotes activation of alpha-secretase. Biochem. Biophys. Res. Commun. 285, 997-1006.